CMS Delays OPPS Payment Cuts For Breakthrough MedicinesDec 19 2001
Washington, D.C. (December 19, 2001) – The Centers for Medicare and Medicaid Services Wednesday postponed by at least three months implementation of a final rule (CMS 1159-2) that would have... |
|
Bipartisan Congressional Letter Urges CMS To Delay Implementation of OPPS ReductionDec 13 2001
WASHINGTON, D.C. - (December 13, 2001) - Sharon L. Cohen, vice president of government relations for the Biotechnology Industry Organization (BIO), released a statement in support of today’s... |
|
BIO Names Philadelphia Host City for BIO 2005Dec 12 2001
Washington, D.C. (December 12, 2001) - The Biotechnology Industry Organization (BIO) has selected Philadelphia as the site of the BIO 2005 International Biotechnology Convention & Exhibition. This... |
|
BIO Names Chicago Host City for BIO 2006Dec 12 2001
Washington, D.C. (December 12, 2001) - The Biotechnology Industry Organization (BIO) has selected Chicago, Illinois, as the site of the BIO 2006 International Biotechnology Convention & Exhibition.... |
|
Toronto to Host World's Premier Biotechnology ConferenceDec 6 2001
WASHINGTON, D.C. (December 6, 2001) – The 16th annual International Biotechnology Convention and Exhibition, BIO 2002, will be held June 9-12 at the Metro Toronto Convention Centre in Toronto... |
|
Biotech CEO & Investor Conference Fosters Industry Partnership and GrowthDec 4 2001
Washington, D.C. (December 4, 2002) - The Biotechnology Industry Organization (BIO) will host the fourth annual CEO & Investor Conference, “Investing in Biotechnology: The Value, The Risks,... |
|
OPPS Cut Harms Patients, Defies Congressional IntentNov 29 2001
Washington, D.C. (November 29, 2001) - The Centers for Medicare and Medicaid Services (formerly HCFA) today published a final rule (CMS 1159-2) slashing by 68.9 percent pro rata pass-through... |
|
BIO Staff Changes Reflect National Security Needs, Higher Public ProfileNov 28 2001
Washington, D.C. (November 28, 2001) - Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO), today announced management changes and department elevations to make BIO’s... |
|
BIO Reiterates Unequivocal Opposition to Reproductive Cloning; Support for Therapeutic ApplicationsNov 25 2001
Washington, D.C. - In response to today’s announcement by Advanced Cell Technology (ACT) of an apparent cloning of a human embryo, the Biotechnology Industry Organization (BIO) reiterates its... |
|
BIO-Europe 2001 Sets Attendance RecordNov 16 2001
November 16, 2001 (Washington, D.C.) - This week’s 7th Annual BIO-Europe partnering conference set a new record for attendance, drawing more than 1,000 executives and investors to Munich. |
